vs
FIRST US BANCSHARES, INC.（FUSB）与Lakeside Holding Ltd（LSH）财务数据对比。点击上方公司名可切换其他公司
FIRST US BANCSHARES, INC.的季度营收约是Lakeside Holding Ltd的1.5倍（$10.4M vs $7.0M），FIRST US BANCSHARES, INC.净利率更高（20.4% vs -22.6%，领先43.0%），Lakeside Holding Ltd同比增速更快（95.0% vs 7.1%）
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
莱克赛德出版社是位于美国芝加哥的出版品牌，由RR唐纳利公司运营。该社除了出版高品质书籍外，还承印邮购目录、电话号码簿、百科全书与广告宣传品，最为人熟知的是为芝加哥卡克斯顿俱乐部出版的高端版本，以及经典重印丛书《莱克赛德经典》。
FUSB vs LSH — 直观对比
营收规模更大
FUSB
是对方的1.5倍
$7.0M
营收增速更快
LSH
高出88.0%
7.1%
净利率更高
FUSB
高出43.0%
-22.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.4M | $7.0M |
| 净利润 | $2.1M | $-1.6M |
| 毛利率 | — | 27.2% |
| 营业利润率 | 28.1% | -21.3% |
| 净利率 | 20.4% | -22.6% |
| 营收同比 | 7.1% | 95.0% |
| 净利润同比 | 24.2% | 18.7% |
| 每股收益（稀释后） | $0.36 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FUSBLSH
| Q4 25 | $10.4M | $7.0M | ||
| Q3 25 | $10.5M | $6.1M | ||
| Q2 25 | $10.3M | $6.3M | ||
| Q1 25 | $9.8M | $3.8M | ||
| Q4 24 | $9.7M | $3.6M | ||
| Q3 24 | $10.1M | $4.1M | ||
| Q2 24 | $10.0M | — | ||
| Q1 24 | $9.9M | — |
净利润FUSBLSH
| Q4 25 | $2.1M | $-1.6M | ||
| Q3 25 | $1.9M | $-1.4M | ||
| Q2 25 | $155.0K | $-893.1K | ||
| Q1 25 | $1.8M | $-1.1M | ||
| Q4 24 | $1.7M | $-1.9M | ||
| Q3 24 | $2.2M | $-1.3M | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | $2.1M | — |
毛利率FUSBLSH
| Q4 25 | — | 27.2% | ||
| Q3 25 | — | 18.2% | ||
| Q2 25 | — | 26.7% | ||
| Q1 25 | — | 18.8% | ||
| Q4 24 | — | -1.2% | ||
| Q3 24 | — | 12.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率FUSBLSH
| Q4 25 | 28.1% | -21.3% | ||
| Q3 25 | 23.9% | -20.8% | ||
| Q2 25 | 1.6% | -8.9% | ||
| Q1 25 | 23.8% | -28.2% | ||
| Q4 24 | 23.8% | -55.6% | ||
| Q3 24 | 29.2% | -32.5% | ||
| Q2 24 | 27.4% | — | ||
| Q1 24 | 27.8% | — |
净利率FUSBLSH
| Q4 25 | 20.4% | -22.6% | ||
| Q3 25 | 18.4% | -22.2% | ||
| Q2 25 | 1.5% | -14.2% | ||
| Q1 25 | 18.1% | -28.2% | ||
| Q4 24 | 17.6% | -54.1% | ||
| Q3 24 | 22.0% | -32.7% | ||
| Q2 24 | 21.2% | — | ||
| Q1 24 | 21.3% | — |
每股收益（稀释后）FUSBLSH
| Q4 25 | $0.36 | $-0.08 | ||
| Q3 25 | $0.32 | $-0.09 | ||
| Q2 25 | $0.03 | $-0.11 | ||
| Q1 25 | $0.29 | $-0.14 | ||
| Q4 24 | $0.29 | $-0.26 | ||
| Q3 24 | $0.36 | $-0.18 | ||
| Q2 24 | $0.34 | — | ||
| Q1 24 | $0.34 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $73.5M | $1.6M |
| 总债务越低越好 | $10.9M | $2.4M |
| 股东权益账面价值 | $105.6M | $12.2M |
| 总资产 | $1.2B | $24.3M |
| 负债/权益比越低杠杆越低 | 0.10× | 0.20× |
8季度趋势，按日历期对齐
现金及短期投资FUSBLSH
| Q4 25 | $73.5M | $1.6M | ||
| Q3 25 | $54.7M | $4.5M | ||
| Q2 25 | $54.0M | $5.0M | ||
| Q1 25 | $56.0M | $1.5M | ||
| Q4 24 | $47.2M | $1.1M | ||
| Q3 24 | $82.3M | $2.7M | ||
| Q2 24 | $58.2M | — | ||
| Q1 24 | $60.2M | — |
总债务FUSBLSH
| Q4 25 | $10.9M | $2.4M | ||
| Q3 25 | $10.9M | $2.4M | ||
| Q2 25 | $10.9M | $1.4M | ||
| Q1 25 | $10.9M | $774.2K | ||
| Q4 24 | $10.9M | $784.8K | ||
| Q3 24 | $10.9M | $589.9K | ||
| Q2 24 | $10.8M | — | ||
| Q1 24 | $10.8M | — |
股东权益FUSBLSH
| Q4 25 | $105.6M | $12.2M | ||
| Q3 25 | $104.2M | $7.0M | ||
| Q2 25 | $101.9M | $2.8M | ||
| Q1 25 | $101.2M | $749.8K | ||
| Q4 24 | $98.6M | $1.6M | ||
| Q3 24 | $98.5M | $3.6M | ||
| Q2 24 | $93.8M | — | ||
| Q1 24 | $92.3M | — |
总资产FUSBLSH
| Q4 25 | $1.2B | $24.3M | ||
| Q3 25 | $1.1B | $18.6M | ||
| Q2 25 | $1.1B | $14.4M | ||
| Q1 25 | $1.1B | $9.9M | ||
| Q4 24 | $1.1B | $9.8M | ||
| Q3 24 | $1.1B | $10.8M | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
负债/权益比FUSBLSH
| Q4 25 | 0.10× | 0.20× | ||
| Q3 25 | 0.10× | 0.35× | ||
| Q2 25 | 0.11× | 0.48× | ||
| Q1 25 | 0.11× | 1.03× | ||
| Q4 24 | 0.11× | 0.48× | ||
| Q3 24 | 0.11× | 0.16× | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.3M | $-453.5K |
| 自由现金流经营现金流 - 资本支出 | $9.1M | — |
| 自由现金流率自由现金流/营收 | 87.2% | — |
| 资本支出强度资本支出/营收 | 31.1% | — |
| 现金转化率经营现金流/净利润 | 5.79× | — |
| 过去12个月自由现金流最近4个季度 | $16.0M | — |
8季度趋势，按日历期对齐
经营现金流FUSBLSH
| Q4 25 | $12.3M | $-453.5K | ||
| Q3 25 | $4.2M | $-4.0M | ||
| Q2 25 | $3.9M | $-483.7K | ||
| Q1 25 | $1.8M | $-238.3K | ||
| Q4 24 | $7.8M | $-530.2K | ||
| Q3 24 | $1.9M | $-1.4M | ||
| Q2 24 | $2.5M | — | ||
| Q1 24 | $825.0K | — |
自由现金流FUSBLSH
| Q4 25 | $9.1M | — | ||
| Q3 25 | $3.6M | — | ||
| Q2 25 | $1.6M | $-497.4K | ||
| Q1 25 | $1.7M | — | ||
| Q4 24 | $5.7M | $-560.5K | ||
| Q3 24 | $1.3M | $-1.4M | ||
| Q2 24 | $2.3M | — | ||
| Q1 24 | $-142.0K | — |
自由现金流率FUSBLSH
| Q4 25 | 87.2% | — | ||
| Q3 25 | 34.2% | — | ||
| Q2 25 | 16.0% | -7.9% | ||
| Q1 25 | 17.2% | — | ||
| Q4 24 | 58.2% | -15.6% | ||
| Q3 24 | 12.7% | -34.5% | ||
| Q2 24 | 23.5% | — | ||
| Q1 24 | -1.4% | — |
资本支出强度FUSBLSH
| Q4 25 | 31.1% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 21.8% | 0.2% | ||
| Q1 25 | 0.7% | 0.0% | ||
| Q4 24 | 21.6% | 0.8% | ||
| Q3 24 | 6.6% | 0.1% | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 9.8% | — |
现金转化率FUSBLSH
| Q4 25 | 5.79× | — | ||
| Q3 25 | 2.18× | — | ||
| Q2 25 | 25.16× | — | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 4.53× | — | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 0.39× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FUSB
暂无分部数据
LSH
| Transferred Over Time | $4.6M | 65% |
| Distribution Of Pharmaceutical Products | $2.4M | 35% |
